Select Cost Of Revenue vs Interest Expense Analysis

SEM Stock

USD 21.34 0.50 2.40%

Select Medical financial indicator trend analysis is much more than just breaking down Select Medical Holdings prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Select Medical Holdings is a good investment. Please check the relationship between Select Medical Cost Of Revenue and its Interest Expense accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Select Medical Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income.

Cost Of Revenue vs Interest Expense

Cost Of Revenue vs Interest Expense Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Select Medical Holdings Cost Of Revenue account and Interest Expense. At this time, the significance of the direction appears to have strong relationship.

The correlation between Select Medical's Cost Of Revenue and Interest Expense is 0.79. Overlapping area represents the amount of variation of Cost Of Revenue that can explain the historical movement of Interest Expense in the same time period over historical financial statements of Select Medical Holdings, assuming nothing else is changed. The correlation between historical values of Select Medical's Cost Of Revenue and Interest Expense is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Cost Of Revenue of Select Medical Holdings are associated (or correlated) with its Interest Expense. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Interest Expense has no effect on the direction of Cost Of Revenue i.e., Select Medical's Cost Of Revenue and Interest Expense go up and down completely randomly.

Correlation Coefficient

0.79

Relationship Direction	Positive
Relationship Strength	Significant

View All Relationships

Cost Of Revenue

Cost of Revenue is found on Select Medical Holdings income statement and represents the costs associated with goods and services Select Medical provides. Indirect cost, such as salaries, is not included. In other words, cost of revenue is the total cost incurred to obtain a sale. It is more than the traditional cost of goods sold, since it includes specific selling and marketing activities.

Interest Expense

The cost incurred by an entity for borrowed funds, including loans, bonds, or lines of credit.

Most indicators from Select Medical's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Select Medical Holdings current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Select Medical Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income.

As of the 28th of November 2024, Sales General And Administrative To Revenue is likely to grow to 0.03, while Selling General Administrative is likely to drop about 119.3 M.

	2021	2022	2023	2024 (projected)
Interest Expense	136.0M	169.1M	198.6M	152.3M
Depreciation And Amortization	202.6M	205.8M	208.7M	135.3M

Interest Expense Depreciation And Amortization

Select Medical fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Good Will	Common Stock Total Equity	Common Stock Shares Outstanding	Short Term Investments	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Short Term Debt
Total Assets		0.98	0.89	0.94	0.73	0.88	0.97	0.64	0.9	0.61	1.0	-0.39	0.64	0.98	0.98	-0.54	0.16	0.37	0.98	0.36	-0.25	0.02	0.99	0.61	0.97	0.75
Short Long Term Debt Total	0.98		0.9	0.94	0.66	0.9	1.0	0.63	0.89	0.55	0.98	-0.43	0.58	0.96	0.95	-0.45	0.04	0.46	0.97	0.41	-0.28	-0.15	0.98	0.62	0.94	0.78
Other Current Liab	0.89	0.9		0.91	0.55	0.81	0.88	0.59	0.83	0.59	0.88	-0.7	0.62	0.89	0.84	-0.29	0.01	0.38	0.86	0.68	-0.59	-0.21	0.89	0.6	0.89	0.75
Total Current Liabilities	0.94	0.94	0.91		0.69	0.86	0.93	0.7	0.91	0.61	0.93	-0.38	0.65	0.94	0.88	-0.47	0.11	0.37	0.87	0.35	-0.24	-0.15	0.92	0.63	0.95	0.87
Total Stockholder Equity	0.73	0.66	0.55	0.69		0.64	0.68	0.7	0.81	0.22	0.74	-0.05	0.23	0.8	0.73	-0.88	0.7	0.24	0.59	-0.02	0.1	0.46	0.63	0.42	0.67	0.48
Property Plant And Equipment Net	0.88	0.9	0.81	0.86	0.64		0.89	0.83	0.81	0.5	0.88	-0.46	0.53	0.86	0.83	-0.56	0.18	0.62	0.84	0.43	-0.26	-0.17	0.87	0.85	0.84	0.88
Net Debt	0.97	1.0	0.88	0.93	0.68	0.89		0.65	0.9	0.47	0.98	-0.42	0.5	0.95	0.94	-0.46	0.03	0.5	0.95	0.39	-0.26	-0.15	0.97	0.62	0.91	0.76
Retained Earnings	0.64	0.63	0.59	0.7	0.7	0.83	0.65		0.7	0.18	0.64	-0.24	0.22	0.7	0.61	-0.73	0.37	0.66	0.52	0.19	-0.01	0.02	0.57	0.84	0.61	0.78
Accounts Payable	0.9	0.89	0.83	0.91	0.81	0.81	0.9	0.7		0.39	0.91	-0.28	0.41	0.93	0.89	-0.58	0.25	0.29	0.83	0.22	-0.12	0.05	0.87	0.54	0.85	0.71
Cash	0.61	0.55	0.59	0.61	0.22	0.5	0.47	0.18	0.39		0.58	-0.33	0.99	0.53	0.57	-0.14	0.06	-0.09	0.64	0.37	-0.34	-0.03	0.65	0.33	0.75	0.55
Non Current Assets Total	1.0	0.98	0.88	0.93	0.74	0.88	0.98	0.64	0.91	0.58		-0.38	0.61	0.98	0.98	-0.55	0.16	0.38	0.98	0.36	-0.24	0.02	0.99	0.62	0.96	0.74
Non Currrent Assets Other	-0.39	-0.43	-0.7	-0.38	-0.05	-0.46	-0.42	-0.24	-0.28	-0.33	-0.38		-0.36	-0.37	-0.35	-0.12	0.16	-0.37	-0.43	-0.99	0.96	0.36	-0.42	-0.42	-0.4	-0.31
Cash And Short Term Investments	0.64	0.58	0.62	0.65	0.23	0.53	0.5	0.22	0.41	0.99	0.61	-0.36		0.56	0.6	-0.16	0.04	-0.04	0.66	0.4	-0.36	-0.07	0.67	0.38	0.78	0.58
Net Receivables	0.98	0.96	0.89	0.94	0.8	0.86	0.95	0.7	0.93	0.53	0.98	-0.37	0.56		0.96	-0.61	0.22	0.4	0.93	0.33	-0.21	0.07	0.95	0.6	0.95	0.74
Good Will	0.98	0.95	0.84	0.88	0.73	0.83	0.94	0.61	0.89	0.57	0.98	-0.35	0.6	0.96		-0.57	0.19	0.32	0.97	0.33	-0.21	0.15	0.97	0.58	0.94	0.66
Common Stock Total Equity	-0.54	-0.45	-0.29	-0.47	-0.88	-0.56	-0.46	-0.73	-0.58	-0.14	-0.55	-0.12	-0.16	-0.61	-0.57		-0.78	-0.28	-0.41	0.18	-0.3	-0.61	-0.43	-0.52	-0.49	-0.41
Common Stock Shares Outstanding	0.16	0.04	0.01	0.11	0.7	0.18	0.03	0.37	0.25	0.06	0.16	0.16	0.04	0.22	0.19	-0.78		-0.12	0.02	-0.21	0.21	0.74	0.04	0.15	0.14	0.04
Short Term Investments	0.37	0.46	0.38	0.37	0.24	0.62	0.5	0.66	0.29	-0.09	0.38	-0.37	-0.04	0.4	0.32	-0.28	-0.12		0.35	0.34	-0.15	-0.37	0.36	0.58	0.31	0.53
Non Current Liabilities Total	0.98	0.97	0.86	0.87	0.59	0.84	0.95	0.52	0.83	0.64	0.98	-0.43	0.66	0.93	0.97	-0.41	0.02	0.35		0.42	-0.3	-0.04	0.99	0.58	0.95	0.69
Inventory	0.36	0.41	0.68	0.35	-0.02	0.43	0.39	0.19	0.22	0.37	0.36	-0.99	0.4	0.33	0.33	0.18	-0.21	0.34	0.42		-0.97	-0.39	0.41	0.41	0.39	0.29
Other Current Assets	-0.25	-0.28	-0.59	-0.24	0.1	-0.26	-0.26	-0.01	-0.12	-0.34	-0.24	0.96	-0.36	-0.21	-0.21	-0.3	0.21	-0.15	-0.3	-0.97		0.36	-0.3	-0.23	-0.28	-0.13
Other Stockholder Equity	0.02	-0.15	-0.21	-0.15	0.46	-0.17	-0.15	0.02	0.05	-0.03	0.02	0.36	-0.07	0.07	0.15	-0.61	0.74	-0.37	-0.04	-0.39	0.36		-0.06	-0.15	-0.01	-0.33
Total Liab	0.99	0.98	0.89	0.92	0.63	0.87	0.97	0.57	0.87	0.65	0.99	-0.42	0.67	0.95	0.97	-0.43	0.04	0.36	0.99	0.41	-0.3	-0.06		0.6	0.97	0.74
Property Plant And Equipment Gross	0.61	0.62	0.6	0.63	0.42	0.85	0.62	0.84	0.54	0.33	0.62	-0.42	0.38	0.6	0.58	-0.52	0.15	0.58	0.58	0.41	-0.23	-0.15	0.6		0.58	0.76
Total Current Assets	0.97	0.94	0.89	0.95	0.67	0.84	0.91	0.61	0.85	0.75	0.96	-0.4	0.78	0.95	0.94	-0.49	0.14	0.31	0.95	0.39	-0.28	-0.01	0.97	0.58		0.78
Short Term Debt	0.75	0.78	0.75	0.87	0.48	0.88	0.76	0.78	0.71	0.55	0.74	-0.31	0.58	0.74	0.66	-0.41	0.04	0.53	0.69	0.29	-0.13	-0.33	0.74	0.76	0.78

Click cells to compare fundamentals

Select Medical Account Relationship Matchups

Select Medical fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	7.3B	7.7B	7.4B	7.7B	7.7B	4.9B
Short Long Term Debt Total	4.5B	4.5B	4.7B	5.1B	5.0B	2.9B
Other Current Liab	535.4M	799.9M	748.5M	656.5M	728.0M	365.1M
Total Current Liabilities	914.3M	1.4B	1.3B	1.2B	1.2B	713.0M
Total Stockholder Equity	929.0M	1.1B	1.3B	1.3B	1.3B	788.0M
Property Plant And Equipment Net	2.0B	2.0B	2.0B	2.2B	2.2B	2.3B
Net Debt	4.2B	3.9B	4.6B	5.0B	4.9B	2.8B
Retained Earnings	279.8M	553.2M	593.3M	581.0M	751.9M	789.4M
Accounts Payable	145.7M	177.1M	233.8M	186.7M	174.3M	131.2M
Cash	335.9M	577.1M	74.3M	97.9M	84.0M	110.8M
Non Current Assets Total	6.1B	6.1B	6.2B	6.4B	6.4B	4.0B
Non Currrent Assets Other	323.9M	319.2M	356.7M	341.7M	60.7M	57.7M
Cash And Short Term Investments	335.9M	577.1M	74.3M	97.9M	143.0M	115.1M
Net Receivables	762.7M	896.8M	889.3M	941.3M	940.3M	597.3M
Good Will	3.4B	3.4B	3.4B	3.5B	3.5B	2.5B
Common Stock Shares Outstanding	130.3M	129.8M	130.2M	124.6M	123.1M	134.7M
Liabilities And Stockholders Equity	7.3B	7.7B	7.4B	7.9B	7.7B	4.9B
Non Current Liabilities Total	5.5B	5.0B	4.8B	5.2B	4.9B	3.3B
Other Current Assets	114.4M	120.2M	175.8M	264.0M	174.3M	236.7M
Other Stockholder Equity	649.1M	509.1M	504.3M	452.2M	493.4M	560.4M
Total Liab	6.4B	6.4B	6.0B	6.3B	6.1B	4.1B
Property Plant And Equipment Gross	2.0B	2.0B	2.0B	1.0B	3.6B	3.8B
Total Current Assets	1.2B	1.6B	1.1B	1.3B	1.3B	829.8M
Accumulated Other Comprehensive Income	0.0	(2.0M)	12.3M	88.6M	42.9M	45.1M
Short Term Debt	233.1M	453.4M	289.3M	311.5M	344.6M	361.8M
Intangible Assets	409.1M	387.5M	374.9M	351.7M	329.9M	233.3M
Other Liab	249.6M	301.1M	249.2M	275.9M	317.3M	200.2M
Other Assets	93.2M	1.4B	356.7M	94.3M	108.5M	202.7M
Long Term Debt	3.4B	3.4B	3.6B	3.8B	3.6B	2.6B
Property Plant Equipment	998.4M	943.4M	961.5M	2.2B	2.5B	2.6B
Net Tangible Assets	(2.1B)	(2.3B)	(2.7B)	804.3M	723.9M	760.1M
Noncontrolling Interest In Consolidated Entity	158.1M	192.5M	215.9M	234.6M	269.8M	283.3M
Retained Earnings Total Equity	279.8M	553.2M	593.3M	581.0M	668.2M	401.2M
Long Term Debt Total	3.4B	3.4B	3.6B	3.8B	4.4B	2.9B
Capital Surpluse	491.0M	509.1M	504.3M	452.2M	520.0M	521.3M

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

When determining whether Select Medical Holdings is a strong investment it is important to analyze Select Medical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Select Medical's future performance. For an informed investment choice regarding Select Stock, refer to the following important reports:

How To Invest In Select

Details

Is Select Stock a good investment?

Details

What is Select Medical's Net Worth?

Details

Largest Health Care Providers & Services Companies

View

Largest Health Care Equipment & Services Companies

View

Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Select Medical Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income.

You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.

Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Select Medical. If investors know Select will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Select Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

0.139

Dividend Share

0.5

Earnings Share

2.14

Revenue Per Share

56.158

Quarterly Revenue Growth

0.057

The market value of Select Medical Holdings is measured differently than its book value, which is the value of Select that is recorded on the company's balance sheet. Investors also form their own opinion of Select Medical's value that differs from its market value or its book value, called intrinsic value, which is Select Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Select Medical's market value can be influenced by many factors that don't directly affect Select Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Select Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Select Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Select Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Select Cost Of Revenue vs Interest Expense Analysis

Cost Of Revenue vs Interest Expense

Cost Of Revenue vs Interest Expense Correlation Analysis

Correlation Coefficient

Cost Of Revenue

Interest Expense

Select Medical fundamental ratios Correlations

Select Medical Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Select Medical fundamental ratios Accounts

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Non Current Assets Total	+ 1.0	Total Assets
Net Debt	+ 1.0	Short Long Term Debt Total
Total Liab	+ 0.99	Total Assets
Cash And Short Term Investments	+ 0.99	Cash
Total Liab	+ 0.99	Non Current Assets Total
Total Liab	+ 0.99	Non Current Liabilities Total

Inventory	- 0.99	Non Currrent Assets Other
Other Current Assets	- 0.97	Inventory
Common Stock Total Equity	- 0.88	Total Stockholder Equity
Common Stock Shares Outstanding	- 0.78	Common Stock Total Equity
Common Stock Total Equity	- 0.73	Retained Earnings
Non Currrent Assets Other	- 0.7	Other Current Liab